US Albuterol Market Hots Up With Lupin ProAir Approval
Analyst Predicts Albuterol ‘End Of The Road’
The market for generic albuterol sulfate is becoming increasingly commoditized in the US, with Lupin announcing FDA approval for generic ProAir – the Indian company’s first device-based inhalation product in the US. Nevertheless, it remains a lucrative opportunity for ANDA sponsors.
